Although earlier studies showed that EZH2 inhibition reduces expression of IRF4, MYC, and PRDM1 in MM, we found that the dual EZH2/G9a inhibition exerted greater suppressive effects than inhibition of either enzyme alone8,9. The gene discussed is IRF4; the disease is Miyoshi myopathy.